![PDF) Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies PDF) Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies](https://www.researchgate.net/profile/Esaki-Muthu-Shankar/publication/51431045/figure/tbl1/AS:601654453862407@1520457008233/Alpha-fetoprotein-positivity-profile-in-hepatocellular-carcinoma-cases-N-142_Q320.jpg)
PDF) Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies
![Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker? | Anticancer Research Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker? | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/5/2711/F1.large.jpg)
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker? | Anticancer Research
![Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma | BMC Gastroenterology | Full Text Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma | BMC Gastroenterology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12876-018-0908-6/MediaObjects/12876_2018_908_Fig2_HTML.png)
Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma | BMC Gastroenterology | Full Text
![Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c1eae23e45b321ff3fb5ebd61780eb875db8cd89/5-Table1-1.png)
Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar
![The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma | Scientific Reports The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-017-12834-1/MediaObjects/41598_2017_12834_Fig1_HTML.jpg)
The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma | Scientific Reports
![JCM | Free Full-Text | Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal? | HTML JCM | Free Full-Text | Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal? | HTML](https://www.mdpi.com/jcm/jcm-08-01736/article_deploy/html/images/jcm-08-01736-g001.png)
JCM | Free Full-Text | Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal? | HTML
![Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation](https://oaepublishstorage.blob.core.windows.net/6f132a3e-4b37-4eba-8452-ecb3e572d0a6/2840.fig.1.png)
Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation
![AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41419-020-03030-7/MediaObjects/41419_2020_3030_Fig1_HTML.png)
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease
![α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study | British Journal of Cancer α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01363-4/MediaObjects/41416_2021_1363_Fig1_HTML.png)